Cineverse Corp. (Cinedigm Corp.) 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Cinedigm Corp. (trading symbol: CIDM) on May 21, 2020, reporting events occurring on May 20, 2020. The filing details the entry into a definitive material agreement for a registered direct offering of Class A common stock.
Key Financial Metrics
- Transaction Type: Registered direct offering of 10,666,666 shares of Class A common stock.
- Share Price: $0.75 per share.
- Gross Proceeds: $8.0 million.
- Net Proceeds: Approximately $7.4 million (after placement agent fees, before estimated offering expenses).
- Placement Agent Fees: 7% of gross proceeds plus expense reimbursement up to $95,000.
- Use of Proceeds: Working capital, general corporate purposes, product development, acquisitions, and capital expenditures.
Note: This filing does not provide data on revenue, profit, cash flow, margins, debt, or liquidity positions as it reports a specific capital raise event rather than periodic financial results.
Material Changes
The primary material change is the execution of a Securities Purchase Agreement with certain investors. The closing of the sale is expected to occur on or about May 22, 2020, subject to customary closing conditions. Benchmark Company LLC and A.G.P./Alliance Global Partners are acting as co-lead placement agents.
Outlook, Risks, and Contingencies
The filing contains forward-looking statements regarding the expected net proceeds and their use. Management notes that actual results could differ materially due to risks and uncertainties inherent in the company's competitive and rapidly changing environment. The company undertakes no obligation to update these forward-looking statements except as required by law. The transaction is contingent upon the satisfaction of customary closing conditions.
Key Facts for Investor Verification
- Verify the closing of the offering on or about May 22, 2020.
- Confirm the final net proceeds after all offering expenses are deducted.
- Monitor the specific allocation of the $7.4 million net proceeds toward acquisitions or product development.
- Review the full text of the Securities Purchase Agreement (Exhibit 10.1) for specific covenants and representations.